COMMUNIQUÉS West-GlobeNewswire

Taconic Biosciences Announces the Formation of Scientific Advisory Board

21/02/2018 - 19:03

RENSSELAER, N.Y., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced the formation of its Scientific Advisory Board (SAB) [...]

Nextech’s 2018 EDGE User Conference Brings Together Medical Specialty Professionals for Expansive Knowledge Exchange

21/02/2018 - 18:53

TAMPA, Fla., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, will host its fourth annual user conference, EDGE, February 22- [...]

Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products

21/02/2018 - 17:09

SAN ANTONIO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Mission Pharmacal Company (“Mission”) announced today that it has recently divested several consumer products to MainPointe Pharmaceuticals, LLC (“MainPointe”). In addition [...]

Genmab 2017 Annual Report

21/02/2018 - 17:02

Company Announcement Copenhagen, Denmark; February 21, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today its Annual Report for 2017. Below is a summary of business progress and financial performance for the [...]

Orange County Plastic Surgeon Recognized as OCMA Physician of Excellence and Orange Coast Magazine Top Doctor

21/02/2018 - 17:01

NEWPORT BEACH, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- For the second time, Dr. Semira Bayati, a plastic surgeon in Newport Beach , has been recognized as a Physician of Excellence by the Orange County Medical [...]

Provant Health Chief Information Officer Discusses CIO Roles

21/02/2018 - 16:30

EAST GREENWICH, R.I., Feb. 21, 2018 (GLOBE NEWSWIRE) -- In his CIO Applications article on the CIO Hall of Faces , Tom Basiliere, chief information officer for Provant Health, discusses today’s evolving CIO roles. [...]

Aino Health AB (publ): signs contract with Region Västmanland

21/02/2018 - 16:01

Region Västmanland and Aino Health Sweden AB have signed a contract on a health audit of the region's operations. The project, pursued jointly by Region Västmanland and Aino Health, encompasses a mapping of the current [...]

Dynavax’s HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] Recommended by CDC Advisory Committee on Immunization Practices for the Prevention of Hepatitis B in Adults

21/02/2018 - 15:36

BERKELEY, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization [...]

Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells

21/02/2018 - 15:30

VANCOUVER, British Columbia and SEATTLE, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) today announced the Company has discovered certain cannabinoids that enhance the [...]

Cognoa Hits Major Milestone Towards First AI-Based Autism Diagnostic

21/02/2018 - 15:04

PALO ALTO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cognoa, a company offering an AI-based platform for pediatric behavioral health diagnostics and digital therapeutics, announces that the U.S. Food and Drug [...]

Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes

21/02/2018 - 15:00

New Infusion Set Offers Simpler, Faster, and More Convenient 1 Insulin Pump Experience DUBLIN - February 21, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, services and solutions, today [...]

Imprivata to Showcase Customer Success with E-prescribing for Opioids at HIMSS18

21/02/2018 - 15:00

LEXINGTON, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, will showcase innovative technologies, customer success stories, and best practices for enabling electronic [...]

La Jolla Pharmaceutical Company Announces the Treatment of First Patient in GIAPREZA™ (angiotensin II) Pediatric Study

21/02/2018 - 15:00

SAN DIEGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) today announced that the first pediatric patient has been treated in LJ501-CRH02, La Jolla’s open-label study of GIAPREZA TM ( [...]

CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction

21/02/2018 - 15:00

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News covered the Company’s recent [...]

Tyme Technologies Appoints Tommy G. Thompson to Board of Directors

21/02/2018 - 15:00

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced the appointment of former Wisconsin governor [...]

Abeona Therapeutics Announces Upcoming Conference Participation

21/02/2018 - 14:45

NEW YORK and CLEVELAND, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

21/02/2018 - 14:31

FIT Biotech Oy Company release February 21, 2018 at 3.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]

CRISPR Therapeutics to Participate in Four Upcoming Investor Conferences

21/02/2018 - 14:30

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]

Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee

21/02/2018 - 14:30

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]